2007
DOI: 10.2337/db06-1406
|View full text |Cite
|
Sign up to set email alerts
|

Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans

Abstract: The normal action of insulin to vasodilate and redistribute blood flow in support of skeletal muscle metabolism is impaired in insulin-resistant states. Increased endogenous endothelin contributes to endothelial dysfunction in obesity and diabetes. Here, we test the hypothesis that increased endogenous endothelin action also contributes to skeletal muscle insulin resistance via impairments in insulin-stimulated vasodilation. We studied nine lean and seven obese humans, measuring the metabolic and hemodynamic e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
79
0
5

Year Published

2007
2007
2018
2018

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 106 publications
(91 citation statements)
references
References 54 publications
(67 reference statements)
7
79
0
5
Order By: Relevance
“…We further demonstrated that the vasodilatory effects of insulin were mediated by the release of endothelial nitric oxide, and we and others demonstrated that blocking nitric oxide production in vivo could induce insulin resistance and inhibit glucose uptake by preventing insulin-mediated vasodilation in skeletal muscle (3). Finally, we demonstrated that endothelial dysfunction, characterized by reduced nitric oxide production and exaggerated release of endothelin, was a key feature of human insulin-resistant states (4). The link between insulin resistance and endothelial dysfunction is now widely accepted, and there is broad recognition that insulin's action to enhance its own vascular delivery (and that of its substrates) is integral to its overall action.…”
mentioning
confidence: 78%
“…We further demonstrated that the vasodilatory effects of insulin were mediated by the release of endothelial nitric oxide, and we and others demonstrated that blocking nitric oxide production in vivo could induce insulin resistance and inhibit glucose uptake by preventing insulin-mediated vasodilation in skeletal muscle (3). Finally, we demonstrated that endothelial dysfunction, characterized by reduced nitric oxide production and exaggerated release of endothelin, was a key feature of human insulin-resistant states (4). The link between insulin resistance and endothelial dysfunction is now widely accepted, and there is broad recognition that insulin's action to enhance its own vascular delivery (and that of its substrates) is integral to its overall action.…”
mentioning
confidence: 78%
“…Vasoconstrictor effects of insulin are critically dependent on the activation of extracellular signal-related kinase (ERK) 1/2, which controls ET-1 release by the endothelium (7)(8)(9). Increased ET-1 activity, as observed in insulin-resistant states, has been shown to impair blood flow and glucose uptake (10). In microvessels of insulin-resistant animals, it has been observed that insulin-mediated Akt activation is selectively impaired, whereas ERK1/2 activation is not altered (11).…”
mentioning
confidence: 99%
“…In health, insulin's vasodilatory effect dominates. With endothelial dysfunction, as occurs with obesity and type 2 diabetes, the PI3K pathway appears to be selectively inhibited by low-grade inflammation, FFA, oxidative stress, and reduced perivascular adiponectin release (55,61,75,79,123). In these circumstances, a reduced vasodilatory response or even paradoxical vasoconstriction can be seen with hyperinsulinemia (23,55).…”
Section: E381mentioning
confidence: 99%